key: cord-1047464-aqt5n5cg
authors: Nedelcu, Marius; Marx, Ludovic; Lutfi, Rami Edward; Vilallonga, Ramon; Diaconu, Victor; Aboudi, Shadi; De Tudela, Artur Cirera; Ferrer, José Vicente; Ramirez, Jose; Noel, Patrick; Nedelcu, Anamaria; Carandina, Sergio
title: Bariatric surgery in patients with previous COVID-19 infection
date: 2021-04-07
journal: Surg Obes Relat Dis
DOI: 10.1016/j.soard.2021.03.029
sha: 112f54c02856aafe31efc3ee0b27857e32df291c
doc_id: 1047464
cord_uid: aqt5n5cg

INTRODUCTION: Reintroducing bariatric surgery to our communities in a COVID-19 environment was particular to each country. Furthermore, no clear recommendation was made for patients with previous COVID-19 infection and favorable outcome seeking for bariatric surgery. OBJECTIVE: The purpose of the current manuscript is to analyze the risk of specific complications for patients with previous COVID-19 infection who were admitted for bariatric surgery. SETTINGS: 8 high volume private centers from 5 countries METHODS: All patients with morbid obesity disease and previous COVID-19 infection admitted for bariatric surgery were included in the current study. Patients were enrolled from 8 centers and 5 countries and their electronic health data were reviewed retrospectively. The primary outcome was to identify early (<30 days) specific complications related to COVID-19 infection, following bariatric surgery and the secondary outcome was to analyze additional work up to prevent them. RESULTS: Thirty-five patients with a mean age of 40 years (range 21 – 68) and mean BMI of 44.3 kg/m(2) (± 7.4 kg/m(2)) with previous COVID-19 infection underwent different bariatric procedures: 23 cases of sleeve (65.7 %), 7 cases of bypass, and 5 other cases. The symptomatology of the previous COVID-19 infection varied: no symptoms (15 patients), fever and respiratory signs (12 patients), only fever (5 patients), digestive symptoms (2 patients), and isolated respiratory signs (one patient). Only 5 patients (14.2 %) were hospitalized for COVID-19 infection for a mean period of 8.8 days (range 6-15 days). One patient was admitted in intensive care unit and needed invasive mechanical ventilation. The mean interval time from COVID infection to the bariatric surgery was of 11.3 weeks (3 - 34 weeks). Hospital stay was 1.7 days (± 1) and all patients were clinically evaluated one month following the bariatric procedure. There were 2 readmissions and one case of complication: one case of gastric leak treated with laparoscopic drainage and repeated pigtail drain with favorable outcome. No case of other specific complications or mortality were recorded. CONCLUSION: Minor and moderate COVID-19 infections, especially the forms not complicated with invasive mechanical ventilation should not preclude the indication for bariatric surgery. In our experience, the previous COVID-19 infection has not induced additional specific complications following bariatric surgery.

Reintroducing bariatric surgery to our communities in a COVID-19 environment was 60 particular to each country. Every surgical society looked for a structured approach for safely reintroducing bariatric surgery with caution for both undiagnosed asymptomatic or presymptomatic carriers of COVID-19 at the time of surgery carrying the inherent risk of suffering severe complications, and the non-infected patients exposed to contracting the infection in the perioperative period. Furthermore, no clear recommendation was made for patients with favorable outcome after previous COVID infection seeking for bariatric surgery. The purpose of the current manuscript is to analyze the risk of specific complications for patients with previous COVID infection who were admitted for bariatric surgery in different countries. Twelve patients presented with fever and respiratory signs.

• Only fever for 5 patients.

• The digestive symptoms were present at the moment of the diagnosis in 2 patients, exclusively for one patient and associated with fever and respiratory signs for the other patient.

• And isolated respiratory signs were found for only one patient. if several studies have identified male sex as a risk factor for severe COVID-19 and death (19) (20) (21) , in our study's population, the majority of patients included were females (29 out of 180 35 patients). This is explained by the fact that female patients are always more frequent in the surgical groups (5).

Our study has several limitations to consider. First, our data represents 35 patients with previous COVID-19 infection who underwent bariatric surgery, only one patient with severe infections. Only five patients were hospitalized for their COVID-19 infection and one was 185 admitted in the intensive care unit and needed invasive mechanical ventilation. Furthermore, our sample size is relatively small and may reduce our ability to uncover differences when they may in fact exist. However, we were able to abstract a robust conclusion, the bariatric surgery in patients with previous COVID-19 minor and moderate infection has no additional specific complications. • The purpose of the current manuscript is to analyze the risk of specific complications for patients with previous COVID-19 infection who were admitted for bariatric surgery.

• 35 patients were enrolled from 8 centers and 5 countries with previous COVID-19

infection underwent different bariatric procedures: 23 cases of sleeve (65.7 %), 7 cases of bypass, and 5 other cases.

• The symptomatology of the previous COVID-19 infection varied: no symptoms (15 patients), fever and respiratory signs (12 patients), only fever (5 patients), digestive symptoms (2 patients), and isolated respiratory signs (one patient). Only 5 patients (14. 2 %) were hospitalized for COVID-19 infection for a mean period of 8.8 days (range 6-15 days). One patient was admitted in intensive care unit and needed invasive mechanical ventilation.

• No case of specific complications related to COVID-19 infection or mortality were recorded.

• Minor and moderate COVID-19 infections, especially the forms not complicated with invasive mechanical ventilation should not preclude the indication for bariatric surgery.

Global estimates of the prevalence of diabetes for 2010 and 2030

WHO characterizes COVID-19 as a pandemic

Obesity in patients younger than 60 years is a risk 210 factor for COVID-19 hospital admission

High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARSCoV-2) requiring invasive mechanical ventilation

The Impact of Previous History of Bariatric Surgery on Outcome of COVID-19. A Nationwide Medico-Administrative French Study

Unexpected Fatality in Perioperative Period

Bariatric Surgical Practice During the Initial Phase of COVID-19 Outbreak

Recommendations for Metabolic and Bariatric Surgery Duringthe COVID19 Pandemic from 225 IFSO

Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey

The Impact of the COVID-19 Pandemic on 230

Bariatric Surgery: Results from a Worldwide Survey Obes Surg

Effects of COVID-19 lockdown on a bariatric surgery waiting list cohort and its influence in surgical risk perception

The effect of obesity on lung function

Obesity and the risk and outcome of infection

Systemic inflammation mediates the detrimental 240 effects of obesity on asthma control

Does coronavirus disease 2019 disprove the obesity paradox in acute respiratory distress syndrome? Obes Silver Spring Md

COVID-19: IFSO LAC Recommendations for the Resumption of Elective Bariatric Surgery

SOFFCO-MM guidelines for the resumption of bariatric and metabolic surgery during and after the Covid-19 pandemic

IFSO Endoscopy Committee Position Statement on the Practice of Bariatric Endoscopy During the COVID-19 Pandemic

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study